Doppler analysis of uterine perfusion and ovarian stromal blood flow in polycystic ovary syndrome

International Journal of Gynecology and Obstetrics

Volumn 105, Issue 2, 2009, Pages 154-157

  Adali, Ertan ^a   Kolusari, Ali ^a   Adali, Fulya ^b   Yildizhan, Recep ^a   Kurdoglu, Mertihan ^a   Sahin, Hanim Guler ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b Women's and Children's Hospital   (Turkey)

Author keywords

Doppler ultrasound; Ovarian stromal artery; Polycystic ovary syndrome; Uterine artery

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; SOMATOMEDIN C;

ARTICLE; BLOOD FLOW VELOCITY; BODY MASS; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; HIRSUTISM; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; UTERINE ARTERY; UTERUS BLOOD FLOW; WAIST HIP RATIO;

EID: 64049089018     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2008.12.023     Document Type: Article

References (30)

1. Ehrmann D.A. Polycystic ovary syndrome. N Engl J Med 352 12 (2005) 1223-1236
2. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18 6 (1997) 774-800
3. Thierry van Dessel H.J., Lee P.D., Faessen G., Fauser B.C., and Giudice L.C. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome. J Clin Endocrinol Metab 84 9 (1999) 3030-3035
4. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Working Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 1 (2004) 41-47
5. Battaglia C., Artini P.G., D'Ambrogio G., Genazzani A.D., and Genazzani A.R. The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome. Am J Obstet Gynecol 172 1 (1995) 108-113
6. Pan H.A., Wu M.H., Cheng Y.C., Li C.H., and Chang F.M. Quantification of Doppler signal in polycystic ovary syndrome using three-dimensional power Doppler ultrasonography: a possible new marker for diagnosis. Hum Reprod 17 1 (2002) 201-206
7. Resende A.V., Mendes M.C., Dias de Moura M., Mendonca H.C., Gomes Premoli A.C., Reis R.M., et al. Doppler study of the uterine arteries and ovarian stroma in patients with polycystic ovary syndrome. Gynecol Obstet Invest 52 3 (2001) 153-157
8. Aleem F.A., and Predanic M. Transvaginal color Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease. Fertil Steril 65 3 (1996) 510-516
9. Ajossa S., Guerriero S., Paoletti A.M., Orru M., Floris S., Mannias M., et al. Uterine perfusion and hormonal pattern in patients with polycystic ovary syndrome. J Assist Reprod Genet 18 8 (2001) 436-440
10. Pinkas H., Mashiach R., Rabinerson D., Avrech O.M., Royburt M., Rufas O., et al. Doppler parameters of uterine and ovarian stromal blood flow in women with polycystic ovary syndrome and normally ovulating women undergoing controlled ovarian stimulation. Ultrasound Obstet Gynecol 12 3 (1998) 197-200
11. Hatch R., Rosenfield R.L., Kim M.H., and Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 140 7 (1981) 815-830
12. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 7 (1985) 412-419
13. Battaglia C., Artini P.G., Salvatori M., Giulini S., Petraglia F., Maxia N., et al. Ultrasonographic patterns of polycystic ovaries: color Doppler and hormonal correlations. Ultrasound Obstet Gynecol 11 5 (1998) 332-336
14. Battaglia C., Artini P.G., Genazzani A.D., Sgherzi M.R., Salvatori M., Giulini S., et al. Color Doppler analysis in lean and obese women with polycystic ovary syndrome. Ultrasound Obstet Gynecol 7 5 (1996) 342-346
15. Loverro G., Vicino M., Lorusso F., Vimercati A., Greco P., and Selvaggi L. Polycystic ovary syndrome: relationship between insulin sensitivity, sex hormone levels and ovarian stromal blood flow. Gynecol Endocrinol 15 2 (2001) 142-149
16. Chekir C., Nakatsuka M., Kamada Y., Noguchi S., Sasaki A., and Hiramatsu Y. Impaired uterine perfusion associated with metabolic disorders in women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 84 2 (2005) 189-195
17. Ajossa S., Guerriero S., Paoletti A.M., Orru M., and Melis G.B. Hyperinsulinemia and uterine perfusion in patients with polycystic ovary syndrome. Ultrasound Obstet Gynecol 20 3 (2002) 276-280
18. Shinozaki K., Kashiwagi A., Masada M., and Okamura T. Stress and vascular responses: oxidative stress and endothelial dysfunction in the insulin-resistant state. J Pharmacol Sci 91 3 (2003) 187-191
19. Ozkan S., Vural B., Caliskan E., Bodur H., Turkoz E., and Vural F. Color Doppler sonographic analysis of uterine and ovarian artery blood flow in women with polycystic ovary syndrome. J Clin Ultrasound 35 6 (2007) 305-313
20. Steinberg H.O., Brechtel G., Johnson A., Fineberg N., and Baron A.D. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94 3 (1994) 1172-1179
21. Horwitz K.B., and Horwitz L.D. Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids. J Clin Invest 69 4 (1982) 750-758
22. Agrawal R., Sladkevicius P., Engmann L., Conway G.S., Payne N.N., Bekis J., et al. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum Reprod 13 3 (1998) 651-655
23. Iwashita M., Mimuro T., Watanabe M., Setoyama T., Matsuo A., Adachi T., et al. Plasma levels of insulin-like growth factor-I and its binding protein in polycystic ovary syndrome. Horm Res 33 Suppl 2 (1990) 21-26
24. Abd El Aal D.E., Mohamed S.A., Amine A.F., and Meki A.R. Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow. Eur J Obstet Gynecol Reprod Biol 118 2 (2005) 219-224
25. Oosterhuis G.J., Vermes I., Lambalk C.B., Michgelsen H.W., and Schoemaker J. Insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations in fluid from human stimulated follicles. Hum Reprod 13 2 (1998) 285-289
26. Buyalos R.P. Insulin-like growth factors: clinical experience in ovarian function. Am J Med 98 1A (1995) 55S-66S
27. Findlay J.K. Angiogenesis in reproductive tissues. J Endocrinol 111 3 (1986) 357-366
28. Glueck C.J., Wang P., Fontaine R.N., Sieve-Smith L., Tracy T., and Moore S.K. Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. Metabolism 48 12 (1999) 1589-1595
29. Kashyap S., and Claman P. Polycystic ovary disease and the risk of pregnancy-induced hypertension. J Reprod Med 45 12 (2000) 991-994
30. Tekay A., Martikainen H., and Jouppila P. Doppler parameters of the ovarian and uterine blood circulation in ovarian hyperstimulation syndrome. Ultrasound Obstet Gynecol 6 1 (1995) 50-53